- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Vertex Pharmaceuticals Incorporated
Total 287 results
-
Vertex Pharmaceuticals IncorporatedCompletedChronic Hepatitis CUnited States
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedCompletedChronic Hepatitis CAustria, France, Germany, United Kingdom
-
Vertex Pharmaceuticals IncorporatedCompletedChronic Hepatitis C VirusUnited States
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States
-
Vertex Pharmaceuticals IncorporatedTerminatedLung CancerUnited States
-
Vertex Pharmaceuticals IncorporatedCompletedDrug InteractionsUnited States
-
Vertex Pharmaceuticals IncorporatedCompletedRheumatoid ArthritisPoland, Belgium, Romania, Serbia, United States, Puerto Rico, Germany, Hungary, Russian Federation, Croatia
-
Vertex Pharmaceuticals IncorporatedCompletedMultiple Myeloma | Hodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Waldenstrom's Macroglobulinemia | Acute Leukemia | Chronic LeukemiaUnited States
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedRecruiting
-
Vertex Pharmaceuticals IncorporatedRecruiting
-
Vertex Pharmaceuticals IncorporatedRecruitingMyotonic Dystrophy Type 1 (DM1)United Kingdom, Canada, Australia
-
Vertex Pharmaceuticals IncorporatedRecruitingPainful Lumbosacral RadiculopathyUnited States
-
Vertex Pharmaceuticals IncorporatedRecruiting
-
Vertex Pharmaceuticals IncorporatedRecruitingType 1 DiabetesUnited States, Italy, United Kingdom, Canada, Switzerland, Netherlands, Germany
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, United Kingdom, Belgium, Netherlands, France, Denmark, Israel, New Zealand, Australia, Ireland, Sweden, Canada, Germany, Poland, Switzerland, Italy, Austria, Hungary, Greece, Norway
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Belgium, Netherlands, United Kingdom, Canada, Australia, France, Germany, Italy, Czechia, Austria, Sweden, Greece
-
Vertex Pharmaceuticals IncorporatedActive, not recruitingCystic FibrosisSpain, Belgium, Netherlands, France, Canada, Germany, Sweden, Switzerland, Italy, Czechia, Portugal, Austria, Hungary, Norway, Poland
-
Vertex Pharmaceuticals IncorporatedActive, not recruitingAlpha-1 Antitrypsin DeficiencyUnited States, United Kingdom, Germany, Ireland
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Germany, United Kingdom, Canada, Australia, Switzerland, France, Ireland, Belgium, Denmark, Poland
-
Vertex Pharmaceuticals IncorporatedEnrolling by invitationCystic FibrosisUnited States, Australia, Germany, Sweden, Switzerland, France, Netherlands, United Kingdom
-
Vertex Pharmaceuticals IncorporatedCompletedAcute PainUnited States
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedActive, not recruitingCystic FibrosisUnited States, Australia, Germany, Sweden, Switzerland, France, Netherlands, United Kingdom
-
Vertex Pharmaceuticals IncorporatedActive, not recruitingCystic FibrosisUnited States, Spain, United Kingdom, Belgium, Netherlands, Denmark, Israel, New Zealand, France, Australia, Ireland, Germany, Sweden, Canada, Czechia, Switzerland, Portugal, Italy, Austria, Hungary, Norway, Poland, Greece
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Australia, Canada, France, United Kingdom, Germany, Spain, Switzerland, Belgium, Israel, Netherlands, Denmark, Italy, Austria, Ireland, Sweden
-
Vertex Pharmaceuticals IncorporatedCompletedFocal Segmental Glomerulosclerosis (FSGS)United States
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Canada, United Kingdom, Australia, Ireland
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisFrance, Spain, Belgium, Netherlands, Australia, Italy, Czechia
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisSpain, Belgium, Netherlands, France, Canada, Germany, Sweden, Italy, Czechia, Switzerland, Portugal, Austria, Hungary, Norway, Poland
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisBelgium, United Kingdom, Australia, Germany
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Netherlands, United Kingdom, Germany, Portugal
-
Vertex Pharmaceuticals IncorporatedCompletedAcute PainUnited States
-
Vertex Pharmaceuticals IncorporatedCompletedAPOL1-mediated Kidney DiseaseUnited States
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisNetherlands, United Kingdom
-
Vertex Pharmaceuticals IncorporatedTerminatedAlpha 1-Antitrypsin DeficiencyUnited States, Germany, Canada, Ireland
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Belgium, Netherlands, Australia, Germany, Ireland, United Kingdom
-
Vertex Pharmaceuticals IncorporatedCompletedSmall Fiber NeuropathyUnited States, Netherlands, Germany, Italy
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisBelgium, United Kingdom, Australia, Germany
-
Vertex Pharmaceuticals IncorporatedCompleted